Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
11 NC counties and 1 VA county are under alert, including Mecklenburg, VA and Northampton counties.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Veracyte, Inc.
< Previous
1
2
3
4
Next >
Veracyte Announces Multiple Studies Reinforcing the Value of Decipher Prostate Testing Will Be Presented at ASTRO 2023
September 28, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte Names Phillip G. Febbo, M.D., as Chief Scientific Officer and Chief Medical Officer
September 27, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte Announces Novel Afirma-Based Findings that Advance Molecular Understanding of Thyroid Cancer to Be Presented at the 2023 ATA Annual Meeting
September 21, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte Names Marie-Claire Taine, Ph.D., as General Manager of Its IVD Business Unit To Advance Global Expansion of the Company’s Tests
September 07, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte and Gustave Roussy Announce Collaboration to Help Biopharmaceutical Companies Accelerate Development of Novel Cancer Therapies
September 06, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
August 29, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte Announces that Findings Published in JCO Precision Oncology Suggest Potential of Decipher GRID-Derived Gene Signatures to Predict Treatment Response in Recurrent Prostate Cancer
August 22, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte Earns Top Workplace Awards in the San Francisco Bay Area and San Diego
August 15, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte Announces Second Quarter 2023 Financial Results
August 08, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Study Published in JNCI Cancer Spectrum Demonstrates Real-World Utility of Veracyte’s Decipher Prostate Genomic Classifier in Prostate Cancer Treatment
August 01, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte to Release Second Quarter 2023 Financial Results on August 8, 2023
July 19, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
New Data Suggest Veracyte’s Afirma Molecular Testing Capabilities Can Help Advance Scientific Understanding of Thyroid Nodules and Cancer
June 20, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte Announces Afirma-Focused Abstracts to Be Presented at ENDO 2023
June 12, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
New Data To Be Shared at 2023 ASCO Demonstrate Power of Veracyte’s Decipher GRID To Help Advance Molecular Understanding of Prostate Cancer
May 25, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
New Data Presented at ATS 2023 Reinforce Clinical Utility of Veracyte’s Genomic Tests in Interstitial Lung Disease and Lung Cancer
May 24, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte to Participate in Upcoming Investor Conferences
May 23, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte Announces that New Data Show Use of the Prosigna Test Significantly Changed Treatment Decisions for Patients with Early-Stage Breast Cancer
May 12, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte Announces First Quarter 2023 Financial Results
May 04, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
New Data Being Presented at AACE 2023 Help Elucidate Cancer Risk of TERT Promoter Gene Mutations in Patients with Indeterminate Thyroid Nodules
May 04, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
New Data Published In Cancer Suggest Decipher GRID-Derived Gene Expression Signature Could Enable More Personalized Treatment for Prostate Cancer Patients
May 03, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte Announces Release of Inaugural ESG Report
May 03, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Data Published in "The Red Journal” Validate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier To Help Guide Therapy in Men with Intermediate-Risk Prostate Cancer
May 02, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Three Abstracts Focusing on the Clinical Utility of Veracyte’s Genomic Tests in ILD and Lung Cancer To Be Presented at ATS 2023 International Conference
May 01, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Findings From Two Large-Scale, Real-World Data Sets Reinforce Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier
April 29, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte Announces Five Abstracts Providing Molecular Insights Into Prostate and Other Cancers To Be Presented at the 2023 ASCO Annual Meeting
April 27, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
New Data Reinforce Ability of Veracyte’s Decipher Prostate Genomic Classifier To Help Identify Prostate Cancer Patients Who Would Benefit from Treatment Intensification
April 17, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte to Release First Quarter 2023 Financial Results on May 4, 2023
April 13, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte Announces Seven Abstracts for Its Decipher Urologic Cancer Tests To Be Presented at 2023 AUA Annual Meeting
April 12, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte Announces Three Abstracts to Be Presented at AACR Annual Meeting 2023 Highlighting the Company’s Multi-Omics Capabilities and Tools for Biopharma Partners
March 15, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
Veracyte Provides Statement on Impact of Events Surrounding Silicon Valley Bank
March 11, 2023
From
Veracyte, Inc.
Via
Business Wire
Tickers
VCYT
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.